mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.7 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.7 |